4 unchanged sentences
INDEX TO EXHIBITS
−Removed: Form of Common Warrant issued in July 3, 2024 offering (incorporated by reference to exhibit 4.1 of the Form 8-K filed July 3, 2024)
−Removed: Form of Pre-Funded Warrant (incorporated by reference to exhibit 4.1 of the Form 8-K filed October 24, 2024)
−Removed: Financial Advisory Agreement dated July 3, 2024 by and among CNS Pharmaceuticals, Inc., A.G.P./Alliance Global Partners (incorporated by reference to exhibit 10.2 of the Form 8-K filed June 26, 2024)
−Removed: Form of Securities Purchase Agreement (incorporated by reference to exhibit 10.1 of the Form 8-K filed July 3, 2024)
−Removed: Sales Agreement, dated July 26, 2024, by and between CNS Pharmaceuticals, Inc.
−Removed: and A.G.P./Alliance Global Partners (incorporated by reference to exhibit 1.1 of the Form 8-K filed July 26, 2024)
−Removed: Form of Waiver and Consent, dated July 26, 2024 (incorporated by reference to exhibit 10.1 of the Form 8-K filed July 26, 2024)
−Removed: Exclusive License Agreement between CNS Pharmaceuticals, Inc.
−Removed: and Cortice Biosciences, Inc.
−Removed: (incorporated by reference to exhibit 10.1 of the Form 8-K filed July 30, 2024)
−Removed: Stock Purchase Agreement between CNS Pharmaceuticals, Inc.
−Removed: and Cortice Biosciences, Inc.
−Removed: (incorporated by reference to exhibit 10.2 of the Form 8-K filed July 30, 2024)
−Removed: Placement Agency Agreement dated October 23, 2024, between CNS Pharmaceuticals, Inc.
−Removed: and A.G.P./Alliance Global Partners (incorporated by reference to exhibit 1.1 of the Form 8-K filed October 24, 2024)
−Removed: Form of Securities Purchase
−Removed: Agreement (incorporated by reference to exhibit 10.1 of the Form 8-K filed October 24, 2024)
Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934.
13 unchanged sentences
Filed herewith.
−Removed: Pursuant to Item 601(b)(10)(iv) of Regulation S-K promulgated by the SEC, certain portions of this exhibit have been redacted.
−Removed: The Company hereby agrees to furnish supplementally to the SEC, upon its request, an unredacted copy of this exhibit.
The certifications on Exhibit 32 hereto are deemed not “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that Section.
6 unchanged sentences
Chief Executive Officer and Director
−Removed: November 14, 2024
(principal executive officer)
1 unchanged sentence
Chief Financial Officer
−Removed: November 14, 2024
Christopher Downs
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.